Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.033 | 0.7 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |